Local 12: UC startup gains approval for trials
Portable system from Sense Neuro Diagnostics can detect brain injuires
A startup founded by four University of Cincinnati physicians gained FDA approval to move forward with clinical trials for its portable system that can detect brain injuries, Local 12 reported.
Medtech startup Sense Neuro Diagnostics is developing the system, NeuSTAT, to help medical personnel diagnose everything from a traumatic brain injury in battle to a stroke.
“NeuSTAT is a device which will detect blood and for the trial, it’ll be approved to detect blood for someone who may have had a hemorrhagic stroke or bleeding from a traumatic brain injury,” Geoff Klass, CEO of Sense Neuro Diagnostics, said. “Worldwide, there's 50 billion traumatic brain injuries each year, and if you have a traumatic brain injury or if you have a stroke, immediate care is important.”
Sense Neuro Diagnostics hopes for results from the initial trial this year.
Featured image at top: Model of a brain. Photo by Robina Weermeijer on Unsplash
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.